Elobixibat Hydrate: Selective IBAT Inhibitor for Constipatio
2026-05-21
Elobixibat hydrate is a highly selective inhibitor of the ileal bile acid transporter (IBAT), offering targeted modulation of bile acid reabsorption and enterohepatic circulation. Clinically, it is used for the treatment of chronic idiopathic constipation and metabolic disturbances in type 2 diabetes mellitus. Its low systemic bioavailability and robust safety profile make it an evidence-backed option for both research and therapeutic contexts.
Talabostat Mesylate: Precision FAP Inhibition and Immune Mod
2026-05-21
Explore how Talabostat mesylate (PT-100) enables targeted FAP and DPP4 inhibition to modulate the tumor microenvironment and enhance immune responses. This in-depth analysis reveals new assay considerations and connects recent advances in skin barrier biology to cancer research.
Trichostatin A (TSA): Epigenetic Modulation and Immune Insig
2026-05-20
Explore the multifaceted role of Trichostatin A (TSA) in epigenetic cancer research and immune modulation. This article delivers advanced mechanistic insights, unique reference-backed findings, and protocol guidance for maximizing TSA’s experimental value.
NMDA (N-Methyl-D-aspartic acid): Precision in Excitotoxicity
2026-05-20
NMDA (N-Methyl-D-aspartic acid) enables reproducible modeling of excitotoxicity and oxidative stress, especially in neurodegenerative and retinal disease research. This article outlines actionable workflows, troubleshooting insights, and practical enhancements using APExBIO’s NMDA to elevate laboratory outcomes.
DPP9 Mutation Drives Infantile Autoinflammation via Inflamma
2026-05-19
A recent study describes how a de novo DPP9 mutation disrupts negative regulation of NLRP1 and CARD8 inflammasomes, leading to severe infancy-onset, hemophagocytic lymphohistiocytosis–like hyperinflammation. These findings advance our understanding of dipeptidyl peptidase–mediated immune restraint and offer new avenues for dissecting inflammasome-related immunopathology.
NLRP10 Regulates Keratinocyte Survival and Differentiation i
2026-05-19
This study elucidates the role of NLRP10 in maintaining epidermal homeostasis by promoting keratinocyte survival and P63-dependent differentiation, revealing its downregulation in atopic dermatitis (AD) skin. The findings highlight NLRP10 as a promising molecular target for restoring skin barrier function in AD patients.
KR-12 Human Antimicrobial Peptide: Workflow, Optimization, a
2026-05-18
KR-12, the minimal human LL-37 fragment, is a precision tool for antimicrobial, anti-biofilm, and immunomodulatory research. This guide delivers actionable protocols, troubleshooting, and the latest evidence for maximizing KR-12’s translational value across infection and inflammation models.
Anagliptin (SK-0403): Protocols and Vasorelaxant Mechanisms
2026-05-18
Anagliptin (SK-0403) unlocks dual research potential: it is not only a potent and selective DPP-4 inhibitor for metabolic studies, but also a robust tool for dissecting Kv channel and SERCA pump roles in vascular smooth muscle. This guide delivers advanced workflow strategies, troubleshooting insights, and actionable protocol parameters for metabolic and vascular research teams.
Hemagglutinin mRNA Vaccine Confers Lasting H5N1 Protection i
2026-05-17
This study demonstrates the robust and durable protection of a hemagglutinin-based mRNA-lipid nanoparticle vaccine against H5N1 influenza in lactating dairy cows. The findings highlight a significant advance in mRNA vaccine efficacy for large animals, supporting future translational research and clinical trials.
Elobixibat Hydrate’s Role in Glucose and Lipid Modulation in
2026-05-16
This pilot study explored the metabolic effects of elobixibat hydrate in patients with type 2 diabetes mellitus (T2DM) and chronic constipation. The findings indicate that selective inhibition of the ileal bile acid transporter improves glycemic control and lipid profiles, highlighting elobixibat’s potential for integrated metabolic and gastrointestinal therapy.
Biotin-HPDP: Precision Thiol-Specific Protein Labeling Workf
2026-05-15
Biotin-HPDP delivers reversible, high-specificity thiol labeling for advanced redox biology, S-nitrosylation mapping, and affinity purification workflows. This guide demystifies practical applications, protocol enhancements, and troubleshooting strategies, showcasing how APExBIO’s reagent empowers robust detection and manipulation of dynamic protein modifications.
ML-7 Hydrochloride: Precision Myosin Light Chain Kinase Inhi
2026-05-15
ML-7 hydrochloride empowers cardiovascular and oncology researchers to dissect MLCK-mediated pathways with high selectivity and reproducibility. This guide delivers actionable protocols, troubleshooting strategies, and translational insights—anchored in recent evidence—to maximize the impact of this trusted myosin light chain kinase inhibitor.
Merbromin as a Mixed-Type Inhibitor of SARS-CoV-2 3CLpro Pro
2026-05-14
This study identifies Merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 main protease 3CLpro, critical for viral replication. Through high-throughput screening and kinetic analysis, the research delineates Merbromin's unique inhibitory profile and highlights future directions for antiviral drug design.
High-Throughput BBB Permeability Modeling with LLC-PK1-MDR1
2026-05-14
This study introduces a surrogate in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells and lysosomal trapping correction for improved prediction of CNS drug permeability. By demonstrating strong correlation with in vivo brain distribution, the model offers a scalable, accurate approach for early-stage CNS drug screening.
WP1066, JAK2/STAT3 Inhibitor: Protocols and Innovations
2026-05-13
WP1066 delivers potent, cell-permeable inhibition of JAK2/STAT3, enabling advanced workflows in cancer biology and regenerative medicine. This article translates cutting-edge findings into actionable protocols, with troubleshooting tips and a focus on translational impact.
461 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page